FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE

This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other thera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PINTO DE SOUZA ELEANOR, KULKARNI-ALMEIDA ASHA, GANGOPADHYAY ASHOK KUMAR, PANICKER RADHA BHASKAR, KRISHNAN SRIDEVI, GUPTE RAVINDRA DATTATRAYA, LAL BANSI, RAO VADLAMUDI V.S.V, GOLE GOPAL VISHNU
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PINTO DE SOUZA ELEANOR
KULKARNI-ALMEIDA ASHA
GANGOPADHYAY ASHOK KUMAR
PANICKER RADHA BHASKAR
KRISHNAN SRIDEVI
GUPTE RAVINDRA DATTATRAYA
LAL BANSI
RAO VADLAMUDI V.S.V
GOLE GOPAL VISHNU
description This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2010256161A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2010256161A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2010256161A13</originalsourceid><addsrcrecordid>eNrjZNB183QK8vTzd3f1UwhydXYNCPEPUnD0C3F09_fzDA4JBrJdFEI8XD2DFEKDXXkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoYGRqZmhmaGjoTFxqgBb_SZm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE</title><source>esp@cenet</source><creator>PINTO DE SOUZA ELEANOR ; KULKARNI-ALMEIDA ASHA ; GANGOPADHYAY ASHOK KUMAR ; PANICKER RADHA BHASKAR ; KRISHNAN SRIDEVI ; GUPTE RAVINDRA DATTATRAYA ; LAL BANSI ; RAO VADLAMUDI V.S.V ; GOLE GOPAL VISHNU</creator><creatorcontrib>PINTO DE SOUZA ELEANOR ; KULKARNI-ALMEIDA ASHA ; GANGOPADHYAY ASHOK KUMAR ; PANICKER RADHA BHASKAR ; KRISHNAN SRIDEVI ; GUPTE RAVINDRA DATTATRAYA ; LAL BANSI ; RAO VADLAMUDI V.S.V ; GOLE GOPAL VISHNU</creatorcontrib><description>This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101007&amp;DB=EPODOC&amp;CC=US&amp;NR=2010256161A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101007&amp;DB=EPODOC&amp;CC=US&amp;NR=2010256161A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PINTO DE SOUZA ELEANOR</creatorcontrib><creatorcontrib>KULKARNI-ALMEIDA ASHA</creatorcontrib><creatorcontrib>GANGOPADHYAY ASHOK KUMAR</creatorcontrib><creatorcontrib>PANICKER RADHA BHASKAR</creatorcontrib><creatorcontrib>KRISHNAN SRIDEVI</creatorcontrib><creatorcontrib>GUPTE RAVINDRA DATTATRAYA</creatorcontrib><creatorcontrib>LAL BANSI</creatorcontrib><creatorcontrib>RAO VADLAMUDI V.S.V</creatorcontrib><creatorcontrib>GOLE GOPAL VISHNU</creatorcontrib><title>FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE</title><description>This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB183QK8vTzd3f1UwhydXYNCPEPUnD0C3F09_fzDA4JBrJdFEI8XD2DFEKDXXkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoYGRqZmhmaGjoTFxqgBb_SZm</recordid><startdate>20101007</startdate><enddate>20101007</enddate><creator>PINTO DE SOUZA ELEANOR</creator><creator>KULKARNI-ALMEIDA ASHA</creator><creator>GANGOPADHYAY ASHOK KUMAR</creator><creator>PANICKER RADHA BHASKAR</creator><creator>KRISHNAN SRIDEVI</creator><creator>GUPTE RAVINDRA DATTATRAYA</creator><creator>LAL BANSI</creator><creator>RAO VADLAMUDI V.S.V</creator><creator>GOLE GOPAL VISHNU</creator><scope>EVB</scope></search><sort><creationdate>20101007</creationdate><title>FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE</title><author>PINTO DE SOUZA ELEANOR ; KULKARNI-ALMEIDA ASHA ; GANGOPADHYAY ASHOK KUMAR ; PANICKER RADHA BHASKAR ; KRISHNAN SRIDEVI ; GUPTE RAVINDRA DATTATRAYA ; LAL BANSI ; RAO VADLAMUDI V.S.V ; GOLE GOPAL VISHNU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2010256161A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PINTO DE SOUZA ELEANOR</creatorcontrib><creatorcontrib>KULKARNI-ALMEIDA ASHA</creatorcontrib><creatorcontrib>GANGOPADHYAY ASHOK KUMAR</creatorcontrib><creatorcontrib>PANICKER RADHA BHASKAR</creatorcontrib><creatorcontrib>KRISHNAN SRIDEVI</creatorcontrib><creatorcontrib>GUPTE RAVINDRA DATTATRAYA</creatorcontrib><creatorcontrib>LAL BANSI</creatorcontrib><creatorcontrib>RAO VADLAMUDI V.S.V</creatorcontrib><creatorcontrib>GOLE GOPAL VISHNU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PINTO DE SOUZA ELEANOR</au><au>KULKARNI-ALMEIDA ASHA</au><au>GANGOPADHYAY ASHOK KUMAR</au><au>PANICKER RADHA BHASKAR</au><au>KRISHNAN SRIDEVI</au><au>GUPTE RAVINDRA DATTATRAYA</au><au>LAL BANSI</au><au>RAO VADLAMUDI V.S.V</au><au>GOLE GOPAL VISHNU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE</title><date>2010-10-07</date><risdate>2010</risdate><abstract>This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2010256161A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A25%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PINTO%20DE%20SOUZA%20ELEANOR&rft.date=2010-10-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2010256161A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true